Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglinice-GM 2mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Unimac Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Voglinice-GM 2mg/500mg/0.2mg Tablet

Diabetol-Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This triple-combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetol-Trio should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your glycemic control. Continuous use is crucial, even with well-managed blood sugar, as discontinuation without medical guidance can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are vital for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Voglinice-GM 2mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Voglinice-GM 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Voglinice-GM 2mg/500mg/0.2mg tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Voglinice-GM 2mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglinice-GM 2mg/500mg/0.2mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglinice-GM 2mg/500mg/0.2mg tablets should be taken on an empty stomach.

How Voglinice-GM 2mg/500mg/0.2mg Tablet works:

Each Voglinice-GM tablet (2mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Voglinice-GM 2mg/500mg/0.2mg Tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Voglinice-GM 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Voglinice-GM 2mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyUNSAFE

The use of Voglinice-GM 2mg/500mg/0.2mg tablets in patients with kidney disease is likely unsafe and should be omitted. Patients with severe kidney impairment should definitely not use this medication. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Voglinice-GM 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Initiation with a reduced dose is typical for individuals with mild to moderate hepatic dysfunction; however, this medication is contraindicated in those with severe liver disease.

What if you forget to take Voglinice-GM 2mg/500mg/0.2mg Tablet :

Should you forget a dose of Voglinice-GM 2mg/500mg/0.2mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglinice-GM 2mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Voglinice-GM 2mg/500mg/0.2mg Tablet

Voglinice-GM 2mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This medication is unsuitable for type 1 diabetes.
Voglinice-GM 2mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Voglinice-GM 2mg/500mg/0.2mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglinice-GM 2mg/500mg/0.2mg tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Voglinice-GM 2mg/500mg/0.2mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concomitant use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglinice-GM 2mg/500mg/0....
164
MRP 190
13% off